Details for: 29 ESSENTIAL VITAMINS AND MINERALS (FOR PEOPLE 50+)
Product description
Product name: 29 ESSENTIAL VITAMINS AND MINERALS (FOR PEOPLE 50+)
Company name: VITA HEALTH PRODUCTS INC
DIN: 02231519
Status: Cancelled Post Market
Status date: 2005-07-20
| Active ingredient(s) | Strength |
|---|---|
| ASCORBIC ACID (ASCORBIC ACID) | 90 MG |
| BETA-CAROTENE | 3000 UNIT |
| BIOTIN | 45 MCG |
| CALCIUM (CALCIUM PHOSPHATE (DIBASIC), CALCIUM CARBONATE) | 200 MG |
| CHLORINE (POTASSIUM CHLORIDE) | 72 MG |
| CHROMIUM (CHROMIC CHLORIDE) | 100 MCG |
| COPPER (CUPRIC OXIDE) | 2 MG |
| D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) | 10 MG |
| FOLIC ACID | 0.4 MG |
| IODINE (POTASSIUM IODIDE) | 0.15 MG |
| IRON (FERROUS FUMARATE) | 4 MG |
| MAGNESIUM (MAGNESIUM OXIDE) | 100 MG |
| MANGANESE (MANGANESE SULFATE) | 5 MG |
| MOLYBDENUM (SODIUM MOLYBDATE) | 25 MCG |
| NICKEL (NICKEL SULFATE) | 5 MCG |
| NICOTINAMIDE | 40 MG |
| PHOSPHORUS (CALCIUM PHOSPHATE (DIBASIC)) | 125 MG |
| POTASSIUM (POTASSIUM CHLORIDE) | 80 MG |
| SELENIUM (SODIUM SELENATE) | 25 MCG |
| SILICON (SODIUM METASILICATE) | 0.01 MG |
| TIN (STANNOUS CHLORIDE) | 0.01 MG |
| VANADIUM (SODIUM METAVANADATE) | 10 MCG |
| VITAMIN A (VITAMIN A ACETATE) | 3000 UNIT |
| VITAMIN B12 (VITAMIN B12) | 25 MCG |
| VITAMIN B1 (THIAMINE MONONITRATE) | 2.25 MG |
| VITAMIN B2 (VITAMIN B2) | 3.2 MG |
| VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) | 3 MG |
| VITAMIN D3 (VITAMIN D3) | 400 UNIT |
| VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) | 45 UNIT |
| ZINC (ZINC OXIDE) | 15 MG |
Resources
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers
| Resource | Description |
|---|---|
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
For health care professionals
| Resource | Description |
|---|---|
| Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
For researchers
| Resource | Description |
|---|---|
| Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
All resources
| Resource | Description |
|---|---|
| Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
| Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| Resource | Description |
|---|---|
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|